Journal of Atrial Fibrillation
| Trial Name | Trial Type | Status | Conditions | Intervention | Against | Sponsors |
| Atrial Fibrillation (AF) Patients Not Taking Vitamin-K Antagonist (VKA) (web link) | Drug | Active, not recruiting | Persistent or Permanent Non-Valvular Atrial Fibrillation | AZD0837 (Phase II) | Aspirin | AstraZeneca |
| Long-Term Safety in Atrial Fibrillation Patients (web link) | Drug | Active, not recruiting | Paroxysmal Persistent or Permanent Nonvalvular Atrial Fibrillation | AZD0837 (Phase II) | Vitamin-K Antagonists (warfarin) | AstraZeneca |
| Sole-Therapy Treatment of Atrial Fibrillation (web link) | Device | Active, not recruiting | Atrial Fibrillation | Surgical Ablation using the AtriCure Bipolar System (Phase II) | NA | AtriCure, Inc. |
| Concomitant Treatment of Permanent Atrial Fibrillation (web link) | Device | Active, not recruiting | Atrial Fibrillation | Surgical bipolar radiofrequency ablation using the AtriCure Bipolar System (Phase III) | NA | AtriCure, Inc. |
| Atrial Fibrillation Rate Control Therapy Guided By Continuous Ambulatory Monitoring (web link) | Device | Active, not recruiting | Atrial Fibrillation | Mobile Cardiac Outpatient Telemetry | NA | Beth Israel Deaconess Medical Center Cardionet |
| CACAF2 Study: Catheter Ablation for Cure of Atrial Fibrillation (web link) | Device | Active, not recruiting | Atrial Fibrillation | RF ablation (Phase IV) | Drug: Drug therapy | Biosense Webster EMEA |
| Study to Verify Proper Detection of Supraventricular Tachyarrhythmia With Single-Lead Dual-Chamber Implantable Cardioverter-Defibrillators (ADRIA) (web link) | Device | Active, not recruiting | Tachyarrhythmia | Implantable cardioverter-defibrillator (Phase IV) | NA | Biotronik GmbH & Co. KG |
| IDE Study for the Approval of CLS and CRT Pacing Therapies for the Treatment of AF With Ablate and Pace (web link) | Device | Active, not recruiting | Atrial Fibrillation Congestive Heart Failure | Protos DR/CLS and Stratos LV CRT pacemakers | NA | Biotronik, Inc. |
| Follow-up Treatment of Patients With Atrial Fibrillation Who Have Been Previously Treated With BIBR 1048 (web link) | Drug | Active, not recruiting | Atrial Fibrillation Cerebrovascular Accident | Dabigatran etexilate (Phase II) | NA | Boehringer Ingelheim Pharmaceuticals |
| Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate (web link) | Drug | Active, not recruiting | Atrial Fibrillation Cerebrovascular Accident | Dabigatran etexilate (Phase III) | Warfarin | Boehringer Ingelheim Pharmaceuticals |
| Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo (web link) | Drug | Active, not recruiting | Cardiovascular Diseases | Telmisartan (Phase IV) | Combination of Telmisartan and Ramipril | Boehringer Ingelheim Pharmaceuticals |
| CONTAK RENEWAL 3 AVT (web link) | Device | Active, not recruiting | Heart Failure Atrial Fibrillation | CONTAK RENEWAL 3 AVT (Phase III) | NA | Boston Scientific Corporation |
| The Effect of Losartan on Atrial Fibrillation (AF) Burden and Pacemaker Dependence in Patients With Sick Sinus Syndrome (web link) | Drug | Active, not recruiting | Atrial Fibrillation | Losartan | Placebo | Chung Shan Medical University |
| A Study to Assess the Safety of a Potential New Drug in Comparison to the Standard Practice of Dosing With Warfarin for Non-Valvular Atrial Fibrillation (web link) | Drug | Active, not recruiting | Atrial Fibrillation Thromboembolism | Du-176b (Phase II) | DU-176b | Daiichi Sankyo Inc. |
| The Home INR Study (THINRS) (web link) | Procedure | Active, not recruiting | Atrial Fibrillation | Weekly patient self-testing of prothrombin time (Phase IV) | NA | Department of Veterans Affairs VA CSP |
| A Retrospective Analysis of the Use of ACE-Inhibitors and Angiotensin Receptor Blockers (web link) | Procedure | Active, not recruiting | Atrial Fibrillation Atrial Flutter | ACE-Inhibitors and Angiotensin Receptor Blockers (Phase II) | NA | Emory University |
| Prevention Of Recurrence Of Atrial Fibrillation (web link) | Drug | Active, not recruiting | Atrial Fibrillation | SB-207266 (Phase II) | NA | GlaxoSmithKline |
| Study to Characterize Atrial Fibrillation in CHF Patients Indicated for CRT (web link) | Device | Active, not recruiting | Congestive Heart Failure Atrial Fibrillation | Vitatron biventricular pacemaker (Phase IV) | NA | Medtronic - Vitatron |
| DATAS: The Dual Chamber & Atrial Tachyarrhythmias Adverse Events Study (web link) | Device | Active, not recruiting | Implantable Cardioverter-Defibrillators Tachycardia Ventricular Ventricular Fibrillation | Implantable Cardioverter Defibrillator (Phase IV) | NA | Medtronic Bakken Research Center |
| Clinical Investigation of the Medtronic Concerto™ Device (web link) | Device | Active, not recruiting | Congestive Heart Failure Atrial Arrhythmia Atrial Tachyarrhythmia Atrial Fibrillation | Cardiac Resynchronization Therapy+Implantable Cardioverter Defibrillator | NA | Medtronic Cardiac Rhythm Disease Management |
| Managed Ventricular Pacing (MVP) Trial (web link) | Device | Active, not recruiting | Heart Disease | ICD | NA | Medtronic Cardiac Rhythm Disease Management Medtronic |
| CONNECT Study - Clinical Evaluation Of Remote NotificatioN to rEduCe Time to Clinical Decision (web link) | Device | Active, not recruiting | Arrhythmia Tachycardia Atrial Fibrillation Ventricular Fibrillation | Remote Management | In-Office Care | Medtronic Cardiac Rhythm Disease Management Medtronic Symbios Clinical |
| Atrial Fibrillation Incidence, Risk Factors and Genetics (web link) | NA | Active, not recruiting | Atrial Fibrillation Cardiovascular Diseases Heart Diseases Hypertension Cerebrovascular Accident Arrhythmia | NA | NA | National Heart, Lung, and Blood Institute (NHLBI) |
| Pharmacogenetics and Cardiovascular Events (web link) | NA | Active, not recruiting | Cardiovascular Diseases Atrial Fibrillation Cerebrovascular Accident Heart Diseases Myocardial Infarction | NA | NA | National Heart, Lung, and Blood Institute (NHLBI) |
| S.I.F.A. II: Prevention Of Thromboembolic Events In Patients With Nonrheumatic Atrial Fibrillation. (web link) | Drug | Active, not recruiting | Atrial Fibrillation | aspirin (Phase III) | indobufen | Pfizer |
| Best Bypass Surgery (BBS) Trial (web link) | Procedure | Active, not recruiting | Heart Disease Cardiovascular Disease | Coronary artery bypass grafting (Phase III) | NA | Rigshospitalet, Denmark Danish Heart Foundation The Danish Medical Research Council Copenhagen Hospital Corporation |
| Efficacy & Safety of Dronedarone Versus Amiodarone for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation (web link) | Drug | Active, not recruiting | Atrial Fibrillation | dronedarone (SR33589) (Phase III) | amiodarone | Sanofi-Aventis |
| Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A) (web link) | Drug | Active, not recruiting | Atrial Fibrillation Vascular Risk | Clopidogrel (Phase III) | NA | Sanofi-Aventis Bristol-Myers Squibb |
| Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE I) (web link) | Drug | Active, not recruiting | Atrial Fibrillation Cardiovascular Disease | Irbesartan (Phase III) | NA | Sanofi-Aventis Bristol-Myers Squibb |
| Mascot Study: Management of Atrial Fibrillation (AF) Suppression in AF-Heart Failure (HF) COmorbidity Therapy (web link) | Device | Active, not recruiting | Heart Failure Atrial Fibrillation Ventricular Dysfunction | Atrial Overdrive Pacing | NA | St. Jude Medical |
